ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests

May 31, 1974

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977